Arcturus Therapeutics Newsroom

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63

Futu NewsNov 8 20:35

Arcturus Therapeutics: Strong Buy Rating Backed by Promising Kostaive Sales and Promising Pipeline Developments

TipRanksNov 8 20:25

Positive Outlook for Arcturus Therapeutics' Vaccine Production and Distribution Spurs Buy Rating

TipRanksOct 4 14:42

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $63

Futu NewsOct 2 00:32

Arcturus Therapeutics Price Target Maintained With a $63.00/Share by HC Wainwright & Co.

Dow JonesOct 2 00:22

Wells Fargo Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $58

Futu NewsOct 1 17:31

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Futu NewsSep 20 19:31

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Futu NewsSep 17 19:34

Leerink Partners Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating

Futu NewsSep 13 14:32

Arcturus Therapeutics Analyst Ratings

BenzingaSep 10 00:54

William Blair Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating

Futu NewsSep 5 00:32

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Futu NewsSep 4 19:31

Buy Rating Affirmed: Arcturus Therapeutics' Promising Cystic Fibrosis Program Progress

TipRanksSep 4 19:11

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $72

Futu NewsAug 27 19:33

Arcturus Therapeutics Analyst Ratings

BenzingaAug 12 18:52

Arcturus Therapeutics Price Target Raised to $63.00/Share From $60.00 by HC Wainwright & Co.

Dow JonesAug 9 05:09

Arcturus Therapeutics Analyst Ratings

BenzingaAug 9 05:03

HC Wainwright & Co. Maintains Buy on Arcturus Therapeutics, Raises Price Target to $63

BenzingaAug 9 05:03

Arcturus Therapeutics: Buy Rating Affirmed Amid Kostaive Launch and ARCT-810 Clinical Advancements

TipRanksAug 7 18:42

Arcturus Therapeutics Analyst Ratings

BenzingaAug 6 23:24